June 21, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top 10 global biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating exocrine pancreatic insufficiency (EPI), approached Thought Leader Select for support with scientific advisory boards in support of a new product initiative. To meet the strategic needs of the company’s advisory board activities in support of the new treatment, Thought Leader Select will deploy its in-house research group for an assessment of community-based key opinion leaders in gastroenterology throughout the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in multiple areas where they advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
For the national assessment, the Thought Leader Select research group will collaborate with a team of national key opinion leaders in gastroenterology to identify community-based physicians for grassroots-level scientific advisory work. Thought Leader Select will combine the key opinion leader recommendations with the experience data to optimize a pool of leading physicians with broad representation across multiple geographic regions in the US.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships, and a suite of tools to promote collaborative work with KOLs.
“Thought Leader Select is proud to have the opportunity to work in the service of a great company collaborating with key opinion leaders in gastroenterology to bring comfort to scores of patients,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “We are looking forward to helping them engage in compliant ways that will drive this new product successfully in the marketplace, and, in turn, bring patient care in this area to a new level of excellence in outcomes.”
About Thought Leader Select
Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.
Thought Leader Select has supported companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.
Media Contact:
Brian Castle, Director of Global Marketing and Client Relations
Phone: 919-360-9690
E-mail: bcastle@thoughtleaderselect.com
